PACIRA BIOSCIENCES, INC. Deferred Tax Assets, Deferred Income
PACIRA BIOSCIENCES, INC. (PCRX) had Deferred Tax Assets, Deferred Income of $0 as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2023-02-28
- 2022-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2021-12-31: Deferred Tax Assets, Deferred Income $2.43M.
- 2020-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2018-12-31: Deferred Tax Assets, Deferred Income $0.00.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2021-12-31 | $2.43M 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2017-12-31 | $1.84M 10-K · filed 2019-02-28 |
| 2016-12-31 | $3.02M 10-K · filed 2018-02-28 |
| 2015-12-31 | $3.53M 10-K · filed 2017-03-01 |
| 2014-12-31 | $4.07M 10-K · filed 2016-02-25 |
| 2013-12-31 | $1.71M 10-K · filed 2015-02-24 |
| 2012-12-31 | $1.90M 10-K · filed 2014-02-25 |
| 2011-12-31 | $8.74M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |